SUMMIT European Cannabis Insights Summit 2026 — Exclusive industry intelligence Register Now
EVENT Cannabis Europa London 2026 — Europe's cannabis industry unites Get Tickets

Recent Searches

    Colorado’s Cannabis Sales Surpass $15bn But Slowdown Continues 

    By

    This Nov 3rd, join us for the third edition of Business of Cannabis: New York at The Williamsburg Hotel. A day long leadership summit focused on retail, investment & policy across New York and North America. Tickets on-sale now – www.cannabisnewyork.live

    Colorado has now seen more than $15bn generated through the legal sale of cannabis since 2014, when it became the first US state to launch adult-use sales.

    The Colorado Department of Revenue published new sales figures in a press release earlier this week, revealing that the state has now secured $2.5bn in tax revenues from cannabis sales.

    In the first eight months of 2023 (January to August), sales have topped just over $1bn, with $132.4m in both medical and adult-use cannabis being sold in August alone.

    Despite this milestone, the state has been experiencing a gradual but concerning slowdown in sales since a monthly sales peak in 2020.

    At the height of the COVID pandemic, in July 2020, total cannabis sales topped $226.3m, but have since declined, and have come below $150m a month since August 2022.

    Unless the state sees a significant boom in sales throughout the rest of 2023, its likely sales will be down year-on-year for a second year running.

    In 2021 total sales topped $2.28bn, coming slightly above 2020’s $2.19bn and marking the high water mark for state sales. In 2022, this figure fell to $1.77bn, marking a 25% decline.

    10 June 2026 · Berlin Sales end May 29

    European Cannabis
    Insights Summit

    From €216

    200+ industry leaders. Exclusive German market data. A half-day briefing for B2B operators in Europe's most important emerging cannabis market.

    Ben Stevens

    Ben is the editor of Business of Cannabis. Since 2021, he has researched, written, and published the vast majority of the outlet’s content, delivering agenda-setting journalism on regulation, business strategy, and policy across Europe.

    The Briefing / Newsletter

    Insights
    you don't want
    to miss.

    A comprehensive, thoughtfully curated overview of the stories defining today's cannabis sector — breaking news, investigative features, expert commentary, and context-rich analysis to help you navigate events with clarity and confidence.

    • Policy & regulation
    • Markets & deals
    • Clinical & science
    Subscribe free